Nabriva Therapeutics, plc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $433,983 | 47 | 68.3% |
| Food and Beverage | $133,990 | 7,523 | 21.1% |
| Consulting Fee | $67,283 | 46 | 10.6% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| CTA NAB-BC-3781-1014 Phase 1 (clinical sites - CF Study) | $382,772 | 0 | 22 |
| A Phase 1, Non-comparative, Open-Label Study of Pharmacokinetics and Safety of a Single-Dose of ZTI-01 (Fosfomycin for Injection) in Pediatric Subjects (Less than 12 Years of Age) Receiving Standard of Care Antibiotic Therapy for Proven or Suspected Infection or for Peri-operative Prophylaxis | $51,212 | 0 | 25 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Dr. Christian Sandrock, Md, MD | Internal Medicine | Sacramento, CA | $6,701 | $0 |
| Dr. Thomas File, Md, MD | Infectious Disease | Akron, OH | $3,337 | $0 |
| David Bullard, Md, MD | Emergency Medicine | Cleveland, OH | $2,602 | $0 |
| Patrick Flume, Md, MD | Pulmonary Disease | Charleston, SC | $2,203 | $0 |
| Dr. Marianne Muhlebach, Md, MD | Pediatric Pulmonology | Chapel Hill, NC | $2,203 | $0 |
| Dr. Paul Planet, M.d., Ph.d, M.D., PH.D | Pediatric Infectious Diseases | Philadelphia, PA | $2,203 | $0 |
| Dr. Henry Dorkin, Md, MD | Pediatric Pulmonology | Boston, MA | $2,203 | $0 |
| Michael Konstan, Md, MD | Pediatric Pulmonology | Cleveland, OH | $2,203 | $0 |
| David Nichols, M.d, M.D | Pediatric Pulmonology | Seattle, WA | $2,203 | $0 |
| Dr. Rohit Gupta, M.d, M.D | Pulmonary Disease | Philadelphia, PA | $2,158 | $0 |
| Parth Rali, Md, MD | Pulmonary Disease | Philadelphia, PA | $2,058 | $0 |
| Joseph Varon, Md, MD | Internal Medicine | Houston, TX | $1,819 | $0 |
| Jinesh Mehta, M.d, M.D | Pulmonary Disease | Weston, FL | $1,790 | $0 |
| Corey Kershaw, Md, MD | Critical Care Medicine | Dallas, TX | $1,788 | $0 |
| Dr. Ruben Penaranda, Md, MD | Internal Medicine | Coral Gables, FL | $1,785 | $0 |
| Dr. Scott Beegle, M.d, M.D | Internal Medicine | Albany, NY | $1,784 | $0 |
| Dr. Mehdi Mirsaeidi, M.d, M.D | Pulmonary Disease | Austin, TX | $1,784 | $0 |
| Anas Hadeh, Md, MD | Pulmonary Disease | Weston, FL | $1,784 | $0 |
| Alan Fein, Md, MD | Pulmonary Disease | Lake Success, NY | $1,783 | $0 |
| Burton Dickey, M.d, M.D | Pulmonary Disease | Houston, TX | $1,782 | $0 |
| Ajay Sheshadri, Md, MD | Pulmonary Disease | Houston, TX | $1,782 | $0 |
| Dr. Lindley Barbee, Md, Mph, MD, MPH | Infectious Disease | Seattle, WA | $1,540 | $0 |
| Anne Rompalo, M.d, M.D | Infectious Disease | Baltimore, MD | $1,500 | $0 |
| Ann Avery, Md, MD | Infectious Disease | Cleveland, OH | $1,500 | $0 |
| Unknown Provider | — | — | $1,102 | $0 |
About Nabriva Therapeutics, plc
Nabriva Therapeutics, plc has made $635,257 in payments to 4,908 healthcare providers, recorded across 7,616 transactions in the CMS Open Payments database. In 2022, the company paid $460,893. The top product by payment volume is Xenleta ($508,189).
Payments were distributed across 91 medical specialties. The top specialty by payment amount is Internal Medicine ($35,509 to 787 doctors).
Payment categories include: Food & Beverage ($133,990), Consulting ($67,283), Research ($433,983).
Nabriva Therapeutics, plc is associated with 2 products in the CMS Open Payments database.